M. C. Werner

The evolution of Graves’ ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine

J. Romaldini, J. Sgarbi, N. Bromberg, 1992, Journal of endocrinological investigation.

Identification of α3, α4, and α5 chains of type IV collagen as alloantigens for alport posttransplant anti-glomerular basement membrane antibodies

R. Kalluri, G. Wolf, E. Neilson, 2000 .

Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.

R. Kalluri, L. P. Van den Heuvel, G. Wolf, 2000, Transplantation.

Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.

J. Romaldini, C. S. Farah, N. Bromberg, 1983, The Journal of clinical endocrinology and metabolism.

Graves’ disease and Hashimoto’s thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels

J. Romaldini, C. S. Farah, N. Bromberg, 1986, Journal of endocrinological investigation.

Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.

J. Romaldini, C. S. Farah, N. Bromberg, 1991, Thyroid.

Metabolism of glucose and glutamine in lymphocytes from graves' hyperthyroid patients: influence of methimazole treatment

J. Romaldini, R. Curi, M. C. Werner, 1996, Cell biochemistry and function.

Stage-Specific Action of Matrix Metalloproteinases Influences Progressive Hereditary Kidney Disease

Z. Werb, R. Kalluri, M. Zeisberg, 2006, PLoS medicine.

Adverse effects related to antithyroid drugs and their dose regimen.

J. Romaldini, N. Bromberg, M. C. Werner, 2009, Experimental and clinical endocrinology.